We already had article of our weekly updates covering the magnetically navigated robots in the gastroenterological area, here the application for the cardiological domain, which is maybe even more sensitive and nano like.
In a collaboration with Houston Methodist Hospital, researchers from the UH Engineering Robotic Swarm Control Laboratory led by Aaron Becker, assistant professor of electrical and computer engineering, are developing a novel treatment for pulmonary embolism (PE) using millimetre-scale corkscrew shaped robots controlled by a magnetic field. PE is the third most common cardiovascular disease, resulting in up to 300,000 deaths annually.
The project:
➡️️ The project introduces a novel non-invasive method of clot removal
➡️️ The idea involves using a magnetic field to wirelessly steer tiny (6 millimetres long with a diameter of 2.5 mm), corkscrew-shaped robots through large arteries to break up blood clots in patients
➡️ Each robot – known as a miniature magnetic rotating swimmer (MMRS)
➡️️ Electromagnets placed around the patient generates a controlled rotating magnetic field that causes the robot to spin
The advantage:
➡️ could improve patient comfort
➡️ reduce the risk of infection
➡️ ultimately decrease the cost of medical treatments
“Using non-invasive miniature magnetic agents could improve patient comfort, reduce the risk of infection and ultimately decrease the cost of medical treatments,” according to Julien Leclerc, a Cullen College research associate specialising in applied electromagnetics. “
My goal is to quickly bring this technology into the clinical realm and allow patients to benefit from this treatment method as soon as possible.”
Healthcare is an industry designed to provide essential services and care for patients to improve their health and well-being. As digital health companies solidify their services and technologies as a preference for many, and innovations continue to be developed, it’s critical for healthcare startups to understand the needs of patients and physicians.
Essential is:
➡️️ Improving R&D with the voice of patients
➡️ Collaborate with physicians
➡️ Maximising go-to-market strategies
➡️ Ensure easy-to-understand, transparent, and factual language within the go-to-market strategy
➡️️ Provide fuel startups with leading experts
➡️ Applying a Gig economy model to healthcare innovation
By applying a gig economy model to healthcare innovation, flipMD from GoodRx is lowering the barrier for physicians and businesses to connect and collaborate through an easy-to-use online platform.
One CIO names the technologies and leadership strategies he’ll be focused on this year: platform design, ‘Virtual Care 3.0’ and more.
The fundamental idea behind a distributed approach is to give authority and responsibility to those who know best – those who are closer to stakeholders.
Embed the IT team with operations closely.
➡️️ Explore a decentralised model in which top management delegates day-to-day operations
➡️️ Virtual care: Expand the organisation’s current telemedicine solution or establish a new one to figure out how to bring the platform readily to a patient’s house.
➡️️ Map route optimization: improvement of care at home delivery for the clinician who goes and visits the patient’s house.
➡️️ Wearables and remote patient monitoring of many patients simultaneously.
➡️️ Work-from-anywhere: Think about your tech stack and whether those are robust enough for work-from-anywhere with security measures in place.
In a world where medical devices or in vitro diagnostics (IVDs) and health applications are becoming increasingly complex, so too are the requirements and procedures for developing these devices. Today’s engineers often struggle to implement new methods and regulations, while also continuing to work as efficiently as possible when they develop novel technology products.
Each system – or system of systems, in some cases – goes through an engineering lifecycle, which is sometimes referred to as a product development lifecycle. In terms of today’s DevOps and value chains, these life cycles can range from a very early ideation phase to end-of-life activities for an obsolete product.
In some cases, key practices are simply added on to existing legacy workflows, whether it is modern engineering methods or new regulatory requirements:
➡️Agile and Lean Practices in a Regulated Environment
➡️Lean Portfolio Management
➡️Design for Six Sigma / Reliability Engineering
➡️Product Cybersecurity
➡️Data Privacy Engineering
➡️Artificial Intelligence
➡️Computer Systems Assurance
➡️Legacy Quality Management Systems
➡️Truly Integrated Lifecycle
Simply adding spot improvements often results in an inflexible process landscape without an integrated, consistent end-to-end approach.
The integration from initial policy development to the tool workflow, covering everything from portfolio management to post-launch activities is key.
Deloitte has developed a process model for building a truly integrated lifecycle…
As the Medical Device Regulation (MDR) updates, the In-Vitro Diagnostics Regulation (IVDR) was established to update the existing European Union In-Vitro Diagnostic (IVD) Device regulations.
The regulatory update of all market requirements for IVD devices led to the implementation of IVDR in May 2017, with a transition period till 26th of May 2022.
The already tight timeline became even more challenging due to the COVID-19 pandemic. The new IVDs and Class A non-sterile devices had still to comply with the IVDR from May 2022.
If you want to know more about:
➡️️ the new requirements
➡️ the challenge
➡️ the benefits
➡️ ️the transition
then here more details from the Med-Tech Innovation news…
Most medical device inventions start out as a single great idea, but how does that idea become a marketed medical device? Here is a brief overview of how a medical device, which can range from a contact lens to a knee implant to an MRI machine, begins with an idea and ends with its submission to FDA.
➡️ Trial enrollment, FDA regulated study/research, Doctors, Clinical Investigators, Documentation
➡️ Study close out, completeness check, FDA Inspection
➡️ IDE
The video highlights aspects of the Investigational Device Exemption (or IDE) process, and provides general information on medical device clinical trials.
The audience is device manufacturers and health care professionals.
Here again how robotics can help in Healthcare, here something about surgery, pros and cons.
Many of the world’s top surgeons are learning first-hand what they can do with surgical robots and it’s unlocking a new era in health care.
One experienced surgeon says “If you’re sitting in the robot you feel like you have control over all the technology around you”.
The surgeons who use it:
➡️ must be extremely good trained and have practised it a lot
➡️️ can see more and can be more precise and minimise fatigue due sitting position
➡️ follow multi-step pathways and gain more information about the structures
➡️ have the advantage of precise dissection, 3D vision, tremor filtration
The advantage for the patients:
➡️ certain types of surgeries are less invasive and need shorter time
➡️ reduced pain and discomfort after the surgery
➡️ shorter hospitalisation, greater degree of movement
➡️ faster recovery time and return to normal activities
The disadvantages:
➡️ Surgical time is in some areas likely to be slightly longer than traditional surgery e.g. joint replacements, and exposing patients to theoretically greater risk of infection
➡️ Any computerised system is only as good as the information that is inputted into it. This includes e.g. the quality of the initial CT scans
➡️high costs of the surgical equipment
Today’s surgical robots extend surgeon’s capacities, they filter out hand tremors and allow manoeuvres that even the best surgeon couldn’t pull off with laparoscopic surgery’s typical long-handled tools.
The importance of robots in surgery becomes higher, but won’t completely replace doctors.
Roche’s Elecsys Amyloid Plasma Panel granted FDA Breakthrough Device Designation to enable a timely diagnosis of Alzheimer’s disease.
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the Elecsys® Amyloid Plasma Panel, an innovative new solution to enable Alzheimer’s disease to be detected earlier.
The Elecsys Amyloid Plasma Panel test detects and measures Alzheimer’s disease biomarkers in blood plasma to indicate the need for further confirmatory testing for Alzheimer’s disease.
Roche is the first in-vitro diagnostics manufacturer to receive this designation for a blood- based biomarker test for Alzheimer’s:
➡️️ The Elecsys Amyloid Plasma Panel is intended to be used in conjunction with other clinical information in symptomatic patients who are being evaluated for Alzheimer’s disease and other causes of cognitive decline.
➡️ The Elecsys Amyloid Plasma Panel has the potential to ensure better identification of patients that require further confirmatory testing, supporting a more timely and accessible diagnosis.
➡️️ This minimally invasive blood-based biomarker test can help to streamline a patient’s journey, improving access to diagnosis and helping them better plan for the future.
The key to transforming the life of people with Alzheimer’s disease is to diagnose as early as possible and intervene with the right care plans!
In previous Industry Updates we showed a surgeon robot innovation which was presented in 2014, here is something more actual.
The Rise of actually real and useful Nanobots making use of the rapidly advancing miniaturisation of robotics and microchips through companies such as TSMC, Intel and Samsung.
These tiny computers/robots potentially will:
➡️️ enter our bloodstream
➡️️cross the blood brain barrier
➡️healing diseases such as cancer
➡️ read and write similar to how Brain Computer Interfaces such as Neuralink currently work
➡️️ enable things such as full dive virtual reality
➡️ even increasing the longevity up to 200 years
The future of technology is looking really exciting, and every day is a day closer to the Technological Singularity.
Once Robots learned to walk & think, humans flying to Mars and us finally merging with technology itself.
If you would like to see more interesting posts, visit our knowledge database: https://thaumatec.com/knowledge/
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent. Click HERE to visit our privacy policy.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duration
Description
cookielawinfo-checkbox-analytics
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional
11 months
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy
11 months
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
